Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Immune cells called macrophages, which guard the entry point to the lymph nodes, handcuff these invaders and take them to ...

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...